Newsroom | 99247 results

LOS ANGELES--(BUSINESS WIRE)--Sutter Health is expanding the use of FloPatch, the first wireless, wearable Doppler ultrasound device, across three additional Northern California hospitals: Sutter Solano Medical Center in Vallejo, Sutter’s Mills-Peninsula Medical Center in Burlingame and the Berkeley campus of Sutter’s Alta Bates Summit Medical Center, as part of its ongoing effort to enhance personalized intravenous (IV) fluid management for patients with sepsis and other life-threatening condi...

CHICAGO--(BUSINESS WIRE)--VectorBuilder, a global leader in gene delivery technologies and CDMO solutions, today announced MuteFree™ AAV, a high-stability AAV vector designed to address ITR instability, a common challenge in gene therapy development. The manuscript describing the technology is now available on bioRxiv. Adeno-associated virus (AAV) remains one of the most widely used gene delivery platforms for therapeutic development. However, inconsistencies in manufacturing and variable thera...

EATONTOWN, N.J.--(BUSINESS WIRE)--Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in CNS drug and device development, today announced it has successfully completed an inspection by the U.S. Food and Drug Administration (FDA) with no observations. This outcome underscores Clinilabs continued commitment to the highest standards of regulatory compliance, operational excellence, and patient safety across its clinical research programs. “Each FDA...

PISCATAWAY, N.J.--(BUSINESS WIRE)--Kashiv BioSciences, LLC (“Kashiv”), a vertically integrated biopharmaceutical company, today announced the appointment of Viet Nguyen as Chief Operating Officer and Arlene Wolny as Senior Vice President of Regulatory Affairs. Both leaders will be based in Piscataway, New Jersey. Viet Nguyen has over two decades of leadership experience, with deep expertise in building high-performing teams, scaling complex operations, and driving commercial readiness across mu...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ImmuVia Inc., a biotechnology company developing first-in-class therapies for solid tumors, today announced that it has selected Quantori, a leading provider of digital transformation services and technology for the life sciences and healthcare industries, as a strategic technology partner. ImmuVia will deploy Quantori’s Q-Scientist platform to streamline computational workflows across its preclinical programs, with the goal of compressing development timeline...

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis to debut the next generation of VAL™ (ValGenesis AI) at INTERPHEX 2026. Visit booth 3552 for demos and pilot program information....

PALO ALTO, Calif. & SÃO PAULO--(BUSINESS WIRE)--Overture Life, the global leader in automated IVF, and Spectrun Bio, a specialist in life sciences commercialization and clinical support across Brazil, today announced a strategic partnership to bring the DaVitri automated IVF laboratory platform to Latin America's largest and most active fertility market. By combining Overture's proven automation technology with Spectrun Bio's deep market knowledge, clinical relationships, and local support infr...

ROCKVILLE, Md.--(BUSINESS WIRE)--Linden Lake Labs (“L3”), an early-stage life sciences platform committed to advancing innovative therapies, today announced that its portfolio company, CrossBridge Bio, has entered into a definitive agreement to be acquired by Eli Lilly and Company. Linden Lake Labs participated in CrossBridge Bio’s seed financing round in November 2024, supporting the early development of its differentiated dual-payload antibody-drug conjugate (ADC) platform. “This milestone re...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Antiva reports Phase 1b/2 data showing ABI-2280 clears high-risk HPV with strong efficacy, durability, and safety vs placebo....

CORVALLIS, Ore. & MEDFORD, Mass.--(BUSINESS WIRE)--BioTesserae Inc. (BTC), a biotechnology company focused on innovative veterinary therapeutics, in collaboration with Sunflower Therapeutics PBC, a public benefit corporation transforming global access to protein manufacturing capacity for diverse applications, today announced that BTC-001 was well tolerated in healthy dogs following a single ascending dose study. BTC-001 is a single domain antibody (SdA) that recognizes the immune checkpoint in...